Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AstraZeneca plc (AZN) vs PubMatic Inc (PUBM) Price & Performance

AstraZeneca plcTrade
PubMatic IncTrade

Price performance (Past 24H)

Key statistics

AstraZeneca plc vs PubMatic Inc — how do they compare? AstraZeneca plc trades at $158.2 (market cap $248.14B), while PubMatic Inc trades at $17.52 (market cap $804.41M). The key difference: AstraZeneca plc is far larger — about 308.5× PubMatic Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while PubMatic Inc pays none. Which is the better fit depends on your goals.

AZNPUBM
Market Cap
$248.14B$804.41M
Sector
HealthTechnology
52-Week High
$209.48$17.78
52-Week Low
$147.06$6.28
Enterprise Value
$275.41B$707.54M
Dividend Yield
2.01%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN

About PubMatic Inc

PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.

Read more on PUBM